(Q82536531)

English

The synergistic effect of panobinostat (LBH589) with melphalan or doxorubicin on multiple myeloma cells; rationale for the use of combination regimens in myeloma patients

scientific article published on November 19, 2010

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21093911%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

0 references

The synergistic effect of panobinostat (LBH589) with melphalan or doxorubicin on multiple myeloma cells; rationale for the use of combination regimens in myeloma patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21093911%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

multiple myeloma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Evangelos Terpos

1

object named as

Evangelos Terpos

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21093911

31 August 2024

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21093911

31 August 2024

publication date

19 November 2010

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21093911%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

full work available at URL

https://api.elsevier.com/content/article/PII:S0145212610005126?httpAccept=text/xml

1 reference

10.1016/J.LEUKRES.2010.10.019

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.10.019

31 August 2024

https://api.elsevier.com/content/article/PII:S0145212610005126?httpAccept=text/plain

1 reference

10.1016/J.LEUKRES.2010.10.019

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.10.019

31 August 2024

Leukemia Research

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21093911%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

35

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21093911%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21093911%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

295-296

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21093911%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

The epigenomics of cancer

1

1 reference

10.1016/J.LEUKRES.2010.10.019

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.10.019

31 August 2024

Cancer epigenomics: DNA methylomes and histone-modification maps

2

1 reference

10.1016/J.LEUKRES.2010.10.019

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.10.019

31 August 2024

Histone deacetylases and cancer

3

1 reference

10.1016/J.LEUKRES.2010.10.019

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.10.019

31 August 2024

Development of the pan-DAC inhibitor panobinostat (LBH589): successes and challenges

4

1 reference

10.1016/J.LEUKRES.2010.10.019

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.10.019

31 August 2024

Histone deacetylase inhibitor panobinostat induces clinical responses with associated alterations in gene expression profiles in cutaneous T-cell lymphoma

5

1 reference

10.1016/J.LEUKRES.2010.10.019

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.10.019

31 August 2024

Improved survival of patients with multiple myeloma after the introduction of novel agents and the applicability of the International Staging System (ISS): an analysis of the Greek Myeloma Study Group (GMSG).

6

1 reference

10.1016/J.LEUKRES.2010.10.019

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.10.019

31 August 2024

Phase I study of vorinostat in combination with bortezomib for relapsed and refractory multiple myeloma

7

1 reference

10.1016/J.LEUKRES.2010.10.019

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.10.019

31 August 2024

The histone deacetylase inhibitor LBH589 is a potent antimyeloma agent that overcomes drug resistance.

8

1 reference

10.1016/J.LEUKRES.2010.10.019

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.10.019

31 August 2024

Aggresome induction by proteasome inhibitor bortezomib and alpha-tubulin hyperacetylation by tubulin deacetylase (TDAC) inhibitor LBH589 are synergistic in myeloma cells

9

1 reference

10.1016/J.LEUKRES.2010.10.019

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.10.019

31 August 2024

Synergistic action of the novel HSP90 inhibitor NVP-AUY922 with histone deacetylase inhibitors, melphalan, or doxorubicin in multiple myeloma

10

1 reference

10.1016/J.LEUKRES.2010.10.019

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.10.019

31 August 2024

In vitro and in vivo rationale for the triple combination of panobinostat (LBH589) and dexamethasone with either bortezomib or lenalidomide in multiple myeloma

11

1 reference

10.1016/J.LEUKRES.2010.10.019

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.10.019

31 August 2024

The histone deacetylase inhibitor LBH589 enhances the anti-myeloma effects of chemotherapy in vitro and in vivo

12

1 reference

10.1016/J.LEUKRES.2010.10.019

https://api.crossref.org/works/10.1016/J.LEUKRES.2010.10.019

31 August 2024

Identifiers

10.1016/J.LEUKRES.2010.10.019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21093911%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21093911%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q82536531&oldid=2240604321"